International Journal of Cancer · 1997 · 96 citations · 18 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyCell SignalingApoptosis In CancerApoptosis PharmacologyApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsCalcium SignalingAcute Promyelocytic LeukemiaCalcium Signaling In ApoptosisCalcium-dependent Apoptotic SignalingCalcium-dependent Regulation Of ApoptosisCell Death AssaysCell Viability AssaysIntracellular Calcium ReleaseIntracellular Drug Concentration
The effect of ursolic acid (UA) on tumor cell apoptosis was investigated using HL-60 human promyelocytic leukemia cells as a model cellular system. Treatment with UA resulted in a concentration-dependent decreased cell viability assessed by MTT assay. UA also induced genomic DNA fragmentation, a hallmark of apoptosis, indicating that the mechanism by which UA induced cell death was through apoptosis. The intracellular Ca2+ level was increased by treatment with UA. Intracellular Ca2+ inhibitors, such as intracellular Ca2+-release blockers (dantrolene, TMB-8 and ruthenium red) and an intracellular Ca2+ chelator (BAPTA/AM), significantly blocked the UA-induced increased intracellular Ca+ concentration. These inhibitors also blocked the effects of UA on cell viability and apoptosis. These results suggest that enhanced intracellular Ca2+ signals may be involved in UA-induced apoptosis in HL-60 cells.
18
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Charles L. Sentman, John R. Shutter, David M. Hockenbery et al. · Cell · 1991 · 1.2K citations
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Toshiyuki Miyashita, JC Reed · Blood · 1993 · 876 citations · Full text
Medicine, Cancer Biology, Oncology +13